Results 151 to 160 of about 1,815,731 (375)

Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide [PDF]

open access: yes, 2001
Background: The sulfonylurea glibenclamide (Glib) abolishes the cardioprotective effect of ischemic preconditioning (IP), presumably by inhibiting mitochondrial KATP channel opening in myocytes. Glimepiride (Glim) is a new sulfonylurea reported to affect
Baxter, G.F.   +5 more
core  

Coronary Circulation

open access: yesCambridge International Law Journal, 2019
G. Kassab
semanticscholar   +1 more source

Nanozymes for Non‐Neoplastic Diseases: Catalytic Therapy Redefined

open access: yesAggregate, EarlyView.
Non‐neoplastic diseases pose a significant health burden. Nanozymes, enzyme‐like nanomaterials, offer promising strategies for regulating oxidative stress and inflammation. This review explores their development, structure–function relationships, and therapeutic potential, with a focus on precision medicine through targeted delivery and multimodal ...
Ling Mei   +8 more
wiley   +1 more source

Evaluation of Coronary Circulation after Arterial Switch Operation. [PDF]

open access: yesArq Bras Cardiol, 2021
Baldo MNF   +3 more
europepmc   +1 more source

Coronary Circulation and the Tail of First-Pass Indicator Dilution Curves [PDF]

open access: bronze, 1964
BENNETT L. CROWDER   +2 more
openalex   +1 more source

Macrophage‐derived Extracellular Vesicles Disguised AIEgen/IDO1 Inhibitor Nanoplatform Reactivate “Immune‐Hot” for Photothermal Immunotherapy via Multi‐Dimensionally Reprograms Tumor Microenvironment

open access: yesAggregate, EarlyView.
Illustration of A/I@REHM nanoparticles preparation (A) and “ICB ‐ Repolarization ‐ PTT” like Poseidon's trident synergistically anti‐tumor treatment (B). ABSTRACT Reversing the tumor microenvironment (TME) from “cold” to “hot” tumor represents a pivotal strategy to overcome the clinical bottleneck of poor response rates to immunotherapy in solid tumors.
Xue Li   +8 more
wiley   +1 more source

Redemptive benefit of atorvastatin in the risk factors of coronary artery disease [PDF]

open access: yes, 2011
Cardiovascular disease, in particular coronary artery disease (CAD), is the principal cause of mortality in developed countries. The classical acute phase protein, C-reactive protein (CRP) is an exquisitely sensitive systemic marker of disease ...
Jayaraman Gowri , Arumugam Vijaya Anand , Shanmugam Achiraman , Govindha Raj Archunan , Subramaniyam Kalavathy , Palanisamy Sampath Kumar , Kalaiyarasan Vijaya Kumar Int J Cur Biomed Phar Res.
core  

Home - About - Disclaimer - Privacy